CHIMERIX INC (CMRX)
CMRXDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
JZP3507 | Phase 2 | Meningioma | - | - |
Frequently asked questions
What is in CHIMERIX INC (CMRX)'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in CHIMERIX INC (CMRX)'s (CMRX) pipeline across Phase 2. Its lead program is JZP3507 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CHIMERIX INC (CMRX)'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for CHIMERIX INC (CMRX) (CMRX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CMRX biotech catalysts?→
Add CMRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CHIMERIX INC (CMRX)'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.